Private Advisor Group LLC Increases Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Private Advisor Group LLC increased its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 26.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,990 shares of the health services provider’s stock after acquiring an additional 2,962 shares during the quarter. Private Advisor Group LLC’s holdings in Teladoc Health were worth $128,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in TDOC. Rubric Capital Management LP bought a new position in Teladoc Health in the second quarter worth $45,267,000. Point72 Asset Management L.P. raised its holdings in Teladoc Health by 221.9% in the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after purchasing an additional 3,655,436 shares in the last quarter. Clearline Capital LP raised its holdings in Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after purchasing an additional 3,483,665 shares in the last quarter. Mizuho Markets Americas LLC bought a new position in Teladoc Health in the second quarter worth $3,937,000. Finally, Natixis raised its holdings in Teladoc Health by 106.6% in the first quarter. Natixis now owns 19,898 shares of the health services provider’s stock worth $300,000 after purchasing an additional 319,898 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Down 2.8 %

TDOC stock opened at $9.24 on Friday. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $22.54. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.59 billion, a P/E ratio of -1.60 and a beta of 0.90. The business’s 50-day moving average price is $8.69 and its 200-day moving average price is $9.55.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.51 million for the quarter, compared to analysts’ expectations of $630.50 million. On average, equities research analysts forecast that Teladoc Health, Inc. will post -1.19 EPS for the current year.

Insider Activity at Teladoc Health

In related news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $62,650.00. Following the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at $614,091.72. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Michael Willem Waters sold 4,218 shares of Teladoc Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now directly owns 78,309 shares in the company, valued at approximately $560,692.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,051 shares of company stock valued at $143,565. 0.95% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Evercore ISI increased their price objective on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Canaccord Genuity Group reduced their price target on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 1st. TD Cowen reduced their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Royal Bank of Canada raised their price target on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a report on Wednesday, October 9th. Finally, Oppenheimer reduced their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $11.97.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.